Ketamine and Phencyclidine Reward and Sensitization in Adult and Adolescent Rats

Total Page:16

File Type:pdf, Size:1020Kb

Ketamine and Phencyclidine Reward and Sensitization in Adult and Adolescent Rats CALIFORNIA STATE UNIVERSITY SAN MARCOS THESIS SIGNATURE PAGE THESIS SUBMITTED IN PARTIAL FULFILLMENT OF THE REQUIREMENTS FOR THE DEGREE MASTER OF ARTS IN PSYCHOLOGICAL SCIENCE THESIS TITLE: KETAMINE AND PHENCYCLIDINE REWARD AND SENSITIZATION IN ADULT AND ADOLESCENT RATS AUTHOR: Talal Javed Zafar DATE OF SUCCESSFUL DEFENSE: 12/05/2017 THE THESIS HAS BEEN ACCEPTED BY THE THESIS COMMITTEE IN PARTIAL FULFILLMENT OF THE REQUIREMENTS FOR THE DEGREE OF MASTER OF ARTS IN PSYCHOLOGICAL SCIENCE. Running head: SENSITIZATION AND DISSOCIATIVES 1 Ketamine and Phencyclidine Reward and Sensitization in Adult and Adolescent Rats Talal J. Zafar California State University San Marcos SENSITIZATION AND DISSOCIATIVES 2 Abstract Dissociative drugs, a class that includes ketamine, phencyclidine and related drugs, are popularly abused, especially by teens and young adults in club and rave settings. Despite use by young people, little is known of the effects of these drugs in adolescents, and potential differences between adolescents and adults. The current thesis examined the effects of dissociatives in adolescents and adults in an animal model. Two behavioral responses, locomotor stimulation and ultrasonic vocalizations (USVs) were examined simultaneously following administration of ketamine or phencyclidine in adolescent and adult Sprague-Dawley rats. The effects of repeated administration were examined to determine if behavioral sensitization, a phenomenon that is characterized by an increase in the effect of a drug after repeated adminstration, occurs. Behavioral sensitization has been linked to drug addiction due to neural plasticity. USVs represent a new approach to measuring positive (reward) and negative (aversion) affective states. It was hypothesized that animals treated with ketamine or phencycline would show increases in locomotor activity and 50 kHz vocalizations, and that they will develop sensitization to both. Furthermore, it was hypothesized that adolescent animals would develop more rapid sensitization than adults, and the adolescents would show long-lasting effects of exposure to dissociatives when tested as adults. In Experiment 1, which examined ketamine, the first treatment induced a short-lived stimulant response that was greater in adolescents. Activity increased across days in adults and adolescents, reflecting the development of sensitization, with adolescents showing more rapid sensitization compared to adults. For 50 kHz USVs on Day 1 ketamine induced a short-lived response in adolescents, but not adults, and the adolescent group showed an upward trend in USVs across days, reflecting sensitization. In contrast, adults showed little evidence of sensitization to the USVs. Both adolescents and adults demonstrated persistent sensitization to locomotor behavior when tested 23 days later; only the adolescents showed persistent sensitization to USVs. In Experiment 2, which examined phencyclidine, the first treatment induced a stimulant response that was greater in adolescents. Locomotor activity increased across days for adults and adolescents, reflecting sensitization in both groups, with adolescents showing more rapid sensitization than adults. For 50 kHz USVs on Day 1 phencyclidine induced an increase in adolescents, but not adults. In contrast to our hypothesis USVs in adolescents decreased across days, reflecting the development of tolerance instead of sensitization. Both adolescents and adults demonstrated persistent sensitization in locomotor behavior. For USVs there was persistent tolerance in adolescents when tested 23 days later, but not in adults. The results demonstrate that adolescents are more sensitive to the stimulant and rewarding effects of dissociatives, and that changes following repeated use are dependent on the specific dissociative examined. SENSITIZATION AND DISSOCIATIVES 3 Ketamine and Phencyclidine Reward and Sensitization in Adult and Adolescent Rats Drug abuse is prevalent in the USA and around the world and is typically initiated in adolescence (Johnston, O’Malley, & Bachman, 2013; SAMHSA 2015). Adolescence is a transitional time between childhood and adulthood that is characterized by complex modifications of behavior, brain function and anatomy that mature at different ages. Therefore, the adolescent brain may be affected by drugs of abuse in ways that differ from the adult brain. Exposure to drugs during the adolescent period may increase vulnerability to drug abuse and neuropsychiatric disorders because of the immature brain development (Anthony & Petronis 1995; Ellgren, Spano, & Hurd, 2007). Drug abuse in adolescence is a cause for concern. For instance, opioid drug abuse among adolescents has led to thousands of hospitalizations annually (Unick, Rosenblum, Mars, & Ciccarone, 2013). Adolescent response to drugs of abuse is therefore a growing area of research (Spear & Brake, 1983; Belluzzi, Lee, Oliff, & Leslie, 2004; Zakharova, Leoni, Kichko, & Izenwasser, 2009; Spear & Varlinskaya 2010; Wiley, & Spear, 2013). An effective way to study the effects of drugs of abuse in a controlled scientifically rigorous manner is to utilize animal models. Human subjects have much variability that complicates research on drug responses. Moreover, conducting research on humans with drugs of abuse has ethical implications, particularly in adolescence. If the goal is to find out the long term effects of drugs on the brain, animal models are essential. Importantly, laboratory rats have behavioral, neurochemical, neuroanatomical and developmental parallels to humans, making them excellent tools for neuroscientific research (Lynch, Nicholson, Dance, Morgan, & Foley, 2010). The main goal of this proposed study is to compare the effects of repeated administration of a class of drugs known as dissociatives (including ketamine and phencyclidine) in adolescents SENSITIZATION AND DISSOCIATIVES 4 and adults. Because brain development is incomplete during adolescence it is possible that introducing drugs during this stage of development will differ from adults. For this study, ketamine and phencyclidine were administered repeatedly to compare the changes that take place in adolescence and adulthood. Ketamine and PCP Ketamine and phencyclidine are known as dissociatives because of their distinct effects, including distortion of perception of sight and sound, an experience of separation between the environment and one’s self, and out of body experiences (Dillon, Copeland, & Jansen, 2003; Jansen 2000). These drugs were developed initially as anesthetics, however their use has expanded (Jansen, 2000; Rudgley, 1998). Recreational use of ketamine started to increase in the 1970s and peaked in the 1990s when the drug became popular in the club and rave scene. Common routes of administration for recreational use of ketamine are injection, snorting, smoking (powder added to tobacco or marijuana cigarettes), or swallowing (NIDA, 2015). At low doses, ketamine users claim that the drug is rewarding and has the ability to produce stimulation and excitation, feelings of euphoria, lucid intoxication, and increased empathy (Dillon et al., 2003; Jansen, 2000; Jansen and Darracot-Cankovic, 2001). At higher doses people experience a sometimes frightening experience known as the K-hole, with distortion of space and time, derealization, depersonalization, dissociation, hallucinations, and near-death experiences (Dillon et al., 2003; Muetzelfeldt et al., 2008; Stone & Pilowski, 2006). PCP is also known recreationally as angel dust, sheet, synthetic marijuana and rocket fuel. Routes of administration for PCP are smoking in marijuana or tobacco cigarettes dipped in PCP solution, snorting, or injecting the drug. Once widely used on college campuses during the SENSITIZATION AND DISSOCIATIVES 5 1970s PCP is now relatively rare among college populations and used chiefly in large cities and urban areas (Domino, 1991; Johnston, O’Malley, & Bachman (2014). Its effects are very similar to those of ketamine, but longer lasting. Adolescence Adolescence is a transitional time between childhood and adulthood that is characterized by complex changes in physiology and behavior. Compared to people of other ages, adolescents have higher sensation seeking, risk taking, and reckless behavior. Such behaviors are beneficial to the adolescent’s development of autonomy (Spear, 2000). One of the difficulties that arises from the increased sensation seeking and risk taking is that adolescents may experiment with drugs of abuse. For example, 15-20% of teenagers in the US and several European regions have used marijuana (Cannabis sativa) in the past month (Ellgren et al., 2007). In addition, more than 90% adult smokers first started smoking during adolescence (Faraday, Elliott, & Grunberg, 2001; U.S. Department of Health and Human Services [USDHHS], 2014). The changes in behavior seen during adolescence are accompanied by changes in the brain that are thought to be responsible for the behavioral changes. These changes in brain anatomy and function peak at different ages. For instance, frontal lobe gray matter reaches its maximal volume around 11-12 years of age, temporal lobe cortical gray matter peaks around 16- 17 years, and parietal lobe cortical gray matter peaks between 10-12 years (Lenroot & Giedd, 2006; Spear, 2000). Additionally, myelenation occurs throughout the young adult’s life until roughly age 25 when myelin sheaths are fully developed (Lenroot et al., 2006). Adolescents go through marked changes in the brain and the normal trajectory of brain development
Recommended publications
  • Therapeutic Effect of Agmatine on Neurological Disease: Focus on Ion Channels and Receptors
    Neurochemical Research (2019) 44:735–750 https://doi.org/10.1007/s11064-018-02712-1 REVIEW PAPER Therapeutic Effect of Agmatine on Neurological Disease: Focus on Ion Channels and Receptors Sumit Barua1 · Jong Youl Kim1 · Jae Young Kim1 · Jae Hwan Kim4 · Jong Eun Lee1,2,3 Received: 15 October 2018 / Revised: 19 December 2018 / Accepted: 24 December 2018 / Published online: 4 January 2019 © Springer Science+Business Media, LLC, part of Springer Nature 2019 Abstract The central nervous system (CNS) is the most injury-prone part of the mammalian body. Any acute or chronic, central or peripheral neurological disorder is related to abnormal biochemical and electrical signals in the brain cells. As a result, ion channels and receptors that are abundant in the nervous system and control the electrical and biochemical environment of the CNS play a vital role in neurological disease. The N-methyl-D-aspartate receptor, 2-amino-3-(5-methyl-3-oxo-1,2-oxazol-4-yl) propanoic acid receptor, kainate receptor, acetylcholine receptor, serotonin receptor, α2-adrenoreceptor, and acid-sensing ion channels are among the major channels and receptors known to be key components of pathophysiological events in the CNS. The primary amine agmatine, a neuromodulator synthesized in the brain by decarboxylation of L-arginine, can regu- late ion channel cascades and receptors that are related to the major CNS disorders. In our previous studies, we established that agmatine was related to the regulation of cell differentiation, nitric oxide synthesis, and murine brain endothelial cell migration, relief of chronic pain, cerebral edema, and apoptotic cell death in experimental CNS disorders.
    [Show full text]
  • Agmatine and Agmatine Analogs in the Treatment of Epilepsy, Seizure, and Electroconvulsive Disorders Peter A
    University of Kentucky UKnowledge Pharmaceutical Sciences Faculty Patents Pharmaceutical Sciences 10-19-2010 Agmatine and Agmatine Analogs in the Treatment of Epilepsy, Seizure, and Electroconvulsive Disorders Peter A. Crooks University of Kentucky, [email protected] Aimee K. Bence David R. Worthen Right click to open a feedback form in a new tab to let us know how this document benefits oy u. Follow this and additional works at: https://uknowledge.uky.edu/ps_patents Part of the Pharmacy and Pharmaceutical Sciences Commons Recommended Citation Crooks, Peter A.; Bence, Aimee K.; and Worthen, David R., "Agmatine and Agmatine Analogs in the Treatment of Epilepsy, Seizure, and Electroconvulsive Disorders" (2010). Pharmaceutical Sciences Faculty Patents. 47. https://uknowledge.uky.edu/ps_patents/47 This Patent is brought to you for free and open access by the Pharmaceutical Sciences at UKnowledge. It has been accepted for inclusion in Pharmaceutical Sciences Faculty Patents by an authorized administrator of UKnowledge. For more information, please contact [email protected]. US007816407B2 (12) United States Patent (10) Patent N0.: US 7,816,407 B2 Crooks et al. (45) Date of Patent: Oct. 19, 2010 (54) AGMATINE AND AGMATINE ANALOGS IN The Merck Index, Merck Research Laboratories Division of Merck & THE TREATMENT OF EPILEPSY, SEIZURE, Co., Inc. 1996, p. 35. AND ELECTROCONVULSIVE DISORDERS James O. McNamara, “Drugs Effective in Therapy of the Epilepsies”, Goodman & Gilman’s The Pharmacological Basis of Therapeutics, (75) Inventors: Peter A. Crooks, Lexington, KY (US); Ninth Edition, Chapter 20, pp. 461-486, 1996. Aimee K. Bence, Lexington, KY (US); I. Tayfun Uzbay et al., “Effects of agmatine on ethanol Withdrawal David R.
    [Show full text]
  • Figure S1. Heat Map of R (Pearson's Correlation Coefficient)
    Figure S1. Heat map of r (Pearson’s correlation coefficient) value among different samples including replicates. The color represented the r value. Figure S2. Distributions of accumulation profiles of lipids, nucleotides, and vitamins detected by widely-targeted UPLC-MC during four fruit developmental stages. The colors indicate the proportional content of each identified metabolites as determined by the average peak response area with R scale normalization. PS1, 2, 3, and 4 represents fruit samples collected at 27, 84, 125, 165 Days After Anthesis (DAA), respectively. Three independent replicates were performed for each stages. Figure S3. Differential metabolites of PS2 vs PS1 group in flavonoid biosynthesis pathway. Figure S4. Differential metabolites of PS2 vs PS1 group in phenylpropanoid biosynthesis pathway. Figure S5. Differential metabolites of PS3 vs PS2 group in flavonoid biosynthesis pathway. Figure S6. Differential metabolites of PS3 vs PS2 group in phenylpropanoid biosynthesis pathway. Figure S7. Differential metabolites of PS4 vs PS3 group in biosynthesis of phenylpropanoids pathway. Figure S8. Differential metabolites of PS2 vs PS1 group in flavonoid biosynthesis pathway and phenylpropanoid biosynthesis pathway combined with RNA-seq results. Table S1. A total of 462 detected metabolites in this study and their peak response areas along the developmental stages of apple fruit. mix0 mix0 mix0 Index Compounds Class PS1a PS1b PS1c PS2a PS2b PS2c PS3a PS3b PS3c PS4a PS4b PS4c ID 1 2 3 Alcohols and 5.25E 7.57E 5.27E 4.24E 5.20E
    [Show full text]
  • Vitamin D Receptor Promotes Healthy Microbial Metabolites
    www.nature.com/scientificreports OPEN Vitamin D receptor promotes healthy microbial metabolites and microbiome Ishita Chatterjee1, Rong Lu1, Yongguo Zhang1, Jilei Zhang1, Yang Dai 2, Yinglin Xia1 ✉ & Jun Sun 1 ✉ Microbiota derived metabolites act as chemical messengers that elicit a profound impact on host physiology. Vitamin D receptor (VDR) is a key genetic factor for shaping the host microbiome. However, it remains unclear how microbial metabolites are altered in the absence of VDR. We investigated metabolites from mice with tissue-specifc deletion of VDR in intestinal epithelial cells or myeloid cells. Conditional VDR deletion severely changed metabolites specifcally produced from carbohydrate, protein, lipid, and bile acid metabolism. Eighty-four out of 765 biochemicals were signifcantly altered due to the Vdr status, and 530 signifcant changes were due to the high-fat diet intervention. The impact of diet was more prominent due to loss of VDR as indicated by the diferences in metabolites generated from energy expenditure, tri-carboxylic acid cycle, tocopherol, polyamine metabolism, and bile acids. The efect of HFD was more pronounced in female mice after VDR deletion. Interestingly, the expression levels of farnesoid X receptor in liver and intestine were signifcantly increased after intestinal epithelial VDR deletion and were further increased by the high-fat diet. Our study highlights the gender diferences, tissue specifcity, and potential gut-liver-microbiome axis mediated by VDR that might trigger downstream metabolic disorders. Metabolites are the language between microbiome and host1. To understand how host factors modulate the microbiome and consequently alter molecular and physiological processes, we need to understand the metabo- lome — the collection of interacting metabolites from the microbiome and host.
    [Show full text]
  • Uncovering New Drug Properties in Target-Based Drug-Drug Similarity Networks
    bioRxiv preprint doi: https://doi.org/10.1101/2020.03.12.988600; this version posted June 27, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. Uncovering new drug properties in target-based drug-drug similarity networks Lucret¸iaUdrescu1, Paul Bogdan2, Aimee´ Chis¸ 3, Ioan Ovidiu Sˆırbu3,6, Alexandru Topˆırceanu4, Renata-Maria Varut¸˘ 5, and Mihai Udrescu4,6,* 1”Victor Babes¸” University of Medicine and Pharmacy Timis¸oara, Department of Drug Analysis, Timis¸oara 300041, Romania 2University of Southern California, Ming Hsieh Department of Electrical Engineering, Los Angeles, CA 90089-2563, USA 3”Victor Babes¸” University of Medicine and Pharmacy Timis¸oara, Department of Biochemistry, Timis¸oara 300041, Romania 4University Politehnica of Timis¸oara, Department of Computer and Information Technology, Timis¸oara 300223, Romania 5University of Medicine and Pharmacy of Craiova, Faculty of Pharmacy, Craiova 200349, Romania 6Timis¸oara Institute of Complex Systems, Timis¸oara 300044, Romania *[email protected] ABSTRACT Despite recent advances in bioinformatics, systems biology, and machine learning, the accurate prediction of drug properties remains an open problem. Indeed, because the biological environment is a complex system, the traditional approach – based on knowledge about the chemical structures – cannot fully explain the nature of interactions between drugs and biological targets. Consequently, in this paper, we propose an unsupervised machine learning approach that uses the information we know about drug-target interactions to infer drug properties.
    [Show full text]
  • Role of Amino Acid Metabolism in Angiogenesis T ⁎ Roxana E
    Vascular Pharmacology 112 (2019) 17–23 Contents lists available at ScienceDirect Vascular Pharmacology journal homepage: www.elsevier.com/locate/vph Review Role of amino acid metabolism in angiogenesis T ⁎ Roxana E. Oberkersch, Massimo M. Santoro Department of Biology, University of Padua, Italy ABSTRACT The role of endothelial metabolism represents a crucial element governing the formation and the differentiation of blood vessels, termed angiogenesis. Besides glycolysis and fatty acid oxidation, endothelial cells rely on specific amino acids to proliferate, migrate, and survive. In this review we focus on the metabolism of those amino acids and the intermediates that hold an established function within angiogenesis and endothelial pa- thophysiology. We also discuss recent work which provides a rationale for specific amino acid-restricted diets and its beneficial effects on vascular tissues, including extending the life span and preventing the development of a variety of diseases. 1. Introduction and produce up to 85% of their ATP through aerobic glycolysis [5]. It has been hypothesized that the use of glycolysis as the main source of The vascular system is a multi-branched network lined by en- ATP holds several advantages. High glycolytic flux can produce faster dothelial cells (ECs) which delivers oxygen and nutrients to the tissues ATP with respect to oxidative metabolism, which represents an ad- in the body [1]. The ability to expand this network is a process called vantage for ECs in a hypoxic microenvironment [6]. The anaerobic angiogenesis. This process is vital in many physiological settings and is metabolism of ECs might save oxygen towards becoming perivascular also implicated in the pathogenesis of several disorders including: mural cells [7].
    [Show full text]
  • Agmatine Improves Spatial Memory
    macolog Khales et al., J Pharma Reports 2016, 1:2 ar ic h a P l f R o e l p a o n r r t s u o J Journal of Pharmacological Reports Research Article Article OpenOpen Access Access Agmatine Improves Spatial Memory Consolidation: The Role of Nitric Oxide Golnaz Yadollahi Khales1, Atefeh Khajeh2 and Maryam Moosavi1,3* 1Shiraz Neuroscience Research Center, Shiraz University of Medical Sciences, Shiraz, Iran 2Students Research Committee, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran 3Nanomedicine and Nanobiology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran Abstract Objective: The existence of agmatine in the hippocampus suggests a role in memory formation. Endogenous agmatine increases after training in the hippocampus, howbeit the effect of exogenous agmatine on memory is not consistent yet. This work was aimed to assess the differential effect of systemic agmatine on spatial memory consolidation and retrieval. Additionally L-NAME was used to assess if nitric oxide is involved in the effect of agmatine. Methods: Male Sprague-Dawley rats (250-350 g) were trained in water maze single training session. After 24 h the memory of animals were examined in a probe trial which was consisted of a trial without platform. To assess the effect of agmatine (40 mg/kg) on memory consolidation it was administered immediately after training and to assess its effect on memory retrieval it was injected 30 min before probe trial. In order to evaluate the involvement of nitric oxide, L-NAME (3 mg/kg) was co-administered with agmatine. Results: Post-training injection (to assess consolidation phase) of agmatine improved the performance of animals in probe test, while its pre-probe administration (to assess retrieval phase) had no effect.
    [Show full text]
  • The Role of Opioid and Nitrergic Systems in Dual Modulation of Date Published Online: 31/08/2020; Seizure Susceptibility
    www.als-journal.com/ ISSN 2310-5380/ August 2020 Review Article Advancements in Life Sciences – International Quarterly Journal of Biological Sciences ARTICLE INFO Open Access Date Received: 16/05/2020; Date Revised: 23/08/2020; The role of opioid and nitrergic systems in dual modulation of Date Published Online: 31/08/2020; seizure susceptibility Authors’ Affiliation: 1,3 2,3 1 4 5 1. Department Muhammad Imran Khan , Farid Ullah Shah , Abdul Wahab , Vahid Nikoui *, Ahmad Reza Dehpour * of Pharmacy, Kohat University of Science and Technology, Abstract 26000 Kohat – Pakistan pilepsy is a chronic disorder presented by recurrent episodes of seizures and affect worldwide 2. Department of Biochemistry, Bannu individuals. The underlying mechanism of seizure is still elusive. Hence, there is still a need to determine Medical College, the contribution of various systems in neurobiology and treatment of seizure. Evidence shows that opioid 28100 Bannu, KPK - and nitrergic systems within the brain interact to modulate various physiological and pathological Pakistan E 3. Drug Detoxification conditions including memory, pain, reward, addiction, depression, and seizure. Various studies revealed that Health Welfare Research Center, diverse dose of opioids such as morphine has dual modulation in seizure susceptibility. For instance, it is Bannu, KPK - reported that morphine at lower doses (0.5, 1, and 3 mg/kg) exerts an anticonvulsant effect in experimental Pakistan 4. Razi Drug seizure models, whereas at higher doses (15, 30, and 60 mg/kg) it could exacerbate the seizure. Similarly, Research Center, Iran nitrergic system has also been observed to possess dual effects in modulating the seizure threshold. Therefore, University of Medical Sciences, Tehran - understanding of opioidergic and nitrergic systems interaction in seizure seems important to achieve the Iran successful goal of seizure management.
    [Show full text]
  • Insights Into the Modulation of Dopamine Transporter Function by Amphetamine, Orphenadrine, and Cocaine Binding
    ORIGINAL RESEARCH published: 09 June 2015 doi: 10.3389/fneur.2015.00134 Insights into the modulation of dopamine transporter function by amphetamine, orphenadrine, and cocaine binding Mary Hongying Cheng1, Ethan Block2, Feizhuo Hu1,3, Murat Can Cobanoglu1, Alexander Sorkin2 and Ivet Bahar1*† 1 Department of Computational and Systems Biology, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA, 2 Department of Cell Biology, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA, 3 Department of Pharmacology and Pharmaceutical Sciences, School of Medicine, Tsinghua University, Beijing, China Edited by: Christopher Surratt, Human dopamine (DA) transporter (hDAT) regulates dopaminergic signaling in the central Duquesne University, USA nervous system by maintaining the synaptic concentration of DA at physiological levels, Reviewed by: Nicola B. Mercuri, upon reuptake of DA into presynaptic terminals. DA translocation involves the co-transport University of Rome Tor Vergata, Italy of two sodium ions and the channeling of a chloride ion, and it is achieved via alternating Harald H. Sitte, access between outward-facing (OF) and inward-facing states of DAT. hDAT is a target for Medical University Vienna, Austria Thomas Stockner, addictive drugs, such as cocaine, amphetamine (AMPH), and therapeutic antidepressants. Medical University of Vienna, Austria Our recent quantitative systems pharmacology study suggested that orphenadrine (ORPH), an (in collaboration with Harald H. Sitte) anticholinergic agent and anti-Parkinson drug, might be repurposable as a DAT drug. Previous *Correspondence: Ivet Bahar, studies have shown that DAT-substrates like AMPH or -blockers like cocaine modulate the Department of Computational and function of DAT in different ways. However, the molecular mechanisms of modulation remained Systems Biology, School of Medicine, elusive due to the lack of structural data on DAT.
    [Show full text]
  • (12) STANDARD PATENT (11) Application No. AU 2012204162 B2 (19) AUSTRALIAN PATENT OFFICE
    (12) STANDARD PATENT (11) Application No. AU 2012204162 B2 (19) AUSTRALIAN PATENT OFFICE (54) Title Chemosensory receptor ligand-based therapies (51) International Patent Classification(s) A61K 31/4709 (2006.01) A61P 3/00 (2006.01) A61K 31/155 (2006.01) A61P 3/04 (2006.01) A61K 31/194 (2006.01) A61P 3/10 (2006.01) A61K 31/198 (2006.01) A61P 7/12 (2006.01) A61K 31/20 (2006.01) A61P 19/10 (2006.01) A61K 31/201 (2006.01) A61P 21/00 (2006.01) A61K 31/353 (2006.01) A61P 25/00 (2006.01) A61K 31/575 (2006.01) A61P 25/22 (2006.01) A61K 31/7016 (2006.01) A61P 25/24 (2006.01) A61K 31/7032 (2006.01) A61P 37/00 (2006.01) A61K 31/704 (2006.01) C12N 5/07 (2010.01) A61P 1/00 (2006.01) (21) Application No: 2012204162 (22) Date of Filing: 2012.01.06 (87) WIPO No: W012/094636 (30) Priority Data (31) Number (32) Date (33) Country 61/430,914 2011.01.07 US (43) Publication Date: 2012.07.12 (44) Accepted Journal Date: 2017.04.20 (71) Applicant(s) Elcelyx Therapeutics, Inc. (72) Inventor(s) Baron, Alain D.;Brown, Martin R.;Jones, Christopher R. G.;Beeley, Nigel R. A.;Fineman, Mark S. (74) Agent / Attorney Spruson & Ferguson, L 35 St Martins Tower 31 Market St, Sydney, NSW, 2000, AU (56) Related Art WO 2007/007189 A2 US 2010/0331419 Al WO 2006/086727 A2 (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date W O 2012/094636 A3 12 July 2012 (12.07.2012) W I PO I P CT (51) International Patent Classification:
    [Show full text]
  • Differential Volume Regulation and Calcium Signaling in Two Ciliary Body Cell Types Is Subserved by TRPV4 Channels
    Differential volume regulation and calcium signaling in two ciliary body cell types is subserved by TRPV4 channels Andrew O. Joa, Monika Lakka, Amber M. Fryea, Tam T. T. Phuonga, Sarah N. Redmona, Robin Robertsb, Bruce A. Berkowitzb,c, Oleg Yarishkina, and David Krizaja,d,e,f,1 aDepartment of Ophthalmology & Visual Sciences, University of Utah School of Medicine, Salt Lake City, UT 84132; bDepartment of Anatomy and Cell Biology, Wayne State University, Detroit, MI 48202; cDepartment of Ophthalmology, Wayne State University, Detroit, MI 48202; dCenter for Translational Medicine, Moran Eye Institute, University of Utah, Salt Lake City, UT 84132; eDepartment of Neurobiology & Anatomy, University of Utah, Salt Lake City, UT 84132; and fDepartment of Bioengineering, University of Utah, Salt Lake City, UT 84132 Edited by King-Wai Yau, Johns Hopkins University School of Medicine, Baltimore, MD, and approved February 23, 2016 (received for review August 11, 2015) Fluid secretion by the ciliary body plays a critical and irreplaceable Therefore, aqueous secretion is often targeted by antiglaucoma function in vertebrate vision by providing nutritive support to the medications that include β-adrenergic receptor antagonists, car- cornea and lens, and by maintaining intraocular pressure. Here, we bonic anhydrase inhibitors, α2-adrenergic agonists, and muscarinic identify TRPV4 (transient receptor potential vanilloid isoform 4) cholinergic agonists (7). A key question, however, is whether CB channels as key osmosensors in nonpigmented epithelial (NPE) cells of cells themselves are able to sense force mediated by membrane the mouse ciliary body. Hypotonic swelling and the selective agonist stretch induced by hydrostatic pressure or swelling, and what such ∼ GSK1016790A (EC50 33 nM) induced sustained transmembrane cation mechanisms might be.
    [Show full text]
  • Regulation of Metabolic Products and Gene Expression in Fusarium Asiaticum by Agmatine Addition
    Mycotoxin Res (2013) 29:103–111 DOI 10.1007/s12550-013-0158-y ORIGINAL PAPER Regulation of metabolic products and gene expression in Fusarium asiaticum by agmatine addition Tadahiro Suzuki & Young-Kyung Kim & Hifumi Yoshioka & Yumiko Iwahashi Received: 21 October 2012 /Revised: 26 December 2012 /Accepted: 8 January 2013 /Published online: 31 January 2013 # The Author(s) 2013. This article is published with open access at Springerlink.com Abstract The metabolic products resulting from the culti- contamination of grain with trichothecene mycotoxins vation of F. asiaticum in agmatine were identified using (Bottalico and Perrone 2002; Goswami and Kistler 2004). capillary electrophoresis–time of flight mass spectrometry. The F. graminearum species complex consists of at least 13 Glyoxylic acid was detected from fungal cultures grown in phylogenetically distinct species (Yli-Mattila et al. 2009). agmatine, while it was absent in control cells. The abun- These species tend to produce different, strain-specific trichothe- dance of other metabolic products of the glycolytic pathway cenes including nivalenol, deoxynivalenol (DON), 3- also increased because of agmatine; however, there was no acetyldeoxynivalenol (3ADON), and 15-acetyldeoxynivalnenol increase in the amounts of pyruvic acid or metabolites from (15ADON) (Bottalico and Perrone 2002). Geographically, the tricarboxylic acid cycle. Moreover, gene expression among members of the F. graminearum species complex, levels within Fusarium asiaticum exposed to agmatine were 15ADON producers are
    [Show full text]